Detalhe da pesquisa
1.
Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants.
J Allergy Clin Immunol;
2024 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763170
2.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Allergy;
2024 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38439527
3.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun;
135: 102984, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36621174
4.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
BMC Infect Dis;
23(1): 332, 2023 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37198536
5.
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis;
81(12): 1757-1766, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36357161
6.
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection.
Front Immunol;
15: 1314507, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38487524
7.
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines.
iScience;
26(9): 107619, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37670790
8.
Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination.
Front Neurol;
13: 1032830, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36438945
9.
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Lancet Rheumatol;
4(5): e338-e350, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35317410